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Abstract. 
 
It has been demonstrated previously that 
during mitosis the sites of myosin phosphorylation are 
switched between the inhibitory sites, Ser 1/2, and the 
activation sites, Ser 19/Thr 18 (Yamakita, Y., S. Ya-
mashiro, and F. Matsumura. 1994. 
 
J. Cell Biol.
 
 124:129Ð
137; Satterwhite, L.L., M.J. Lohka, K.L. Wilson, T.Y. 
Scherson, L.J. Cisek, J.L. Corden, and T.D. Pollard. 
1992. 
 
J. Cell Biol.
 
 118:595Ð605), suggesting a regulatory 
role of myosin phosphorylation in cell division. To ex-
plore the function of myosin phosphatase in cell divi-
sion, the possibility that myosin phosphatase activity 
may be altered during cell division was examined. We 
have found that the myosin phosphatase targeting sub-
unit (MYPT) undergoes mitosis-specific phosphoryla-
tion and that the phosphorylation is reversed during cy-
tokinesis. MYPT phosphorylated either in vivo or in 
vitro in the mitosis-specific way showed higher binding 
to myosin II (two- to threefold) compared to MYPT 
from cells in interphase. Furthermore, the activity of 
myosin phosphatase was increased more than twice and 
it is suggested this reflected the increased affinity of 
myosin binding. These results indicate the presence of a 
unique positive regulatory mechanism for myosin phos-
phatase in cell division. The activation of myosin phos-
phatase during mitosis would enhance dephosphoryla-
 
tion of the myosin regulatory light chain, thereby leading 
to the disassembly of stress fibers during prophase. The 
mitosis-specific effect of phosphorylation is lost on exit 
from mitosis, and the resultant increase in myosin phos-
phorylation may act as a signal to activate cytokinesis.
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1. 
 
Abbreviations used in this paper:
 
 MLCK, myosin light chain kinase;
MYPT, myosin phosphatase targeting subunit; pAb, polyclonal antibody;
 
A
 
T
 
 mitosis, normal animal cultured cells show profound
reorganization of the microfilament cytoskeleton.
During prophase, both stress fibers and focal ad-
hesions are disassembled, resulting in cell rounding. At cy-
tokinesis, microfilaments form a contractile ring that con-
tracts to generate daughter cells. During postmitotic cell
spreading, microfilaments reassemble into stress fibers
and focal adhesions are formed. The molecular mecha-
nisms underlying these drastic alterations in the microfila-
ment organization during cell division are largely un-
known.
Phosphorylation of the regulatory light chain of myosin
II (RMLC)
 
1
 
 is thought to regulate actomyosin contractility
in smooth muscle and in many nonmuscle cells (see for re-
view Kamm and Stull, 1985; Moussavi et al., 1993; Somlyo
and Somlyo, 1994). RMLC is phosphorylated by myosin
light chain kinase at two sites, a primary site, Ser 19, and a
secondary site, Thr 18. It can also be phosphorylated (for
example by protein kinase C) at Ser 1 or Ser 2, and Thr 9.
In vitro, the phosphorylation at Ser 19 activates actin-acti-
vated ATPase activity of myosin II (Sellers, 1991; Trybus,
1991) whereas phosphorylation at Ser 1/2 and Thr 9 can in-
hibit ATPase activity of myosin phosphorylated at Ser 19
(Bengur et al., 1987; Ikebe and Reardon, 1990). In vivo,
phosphorylation of Ser 19 is correlated with a variety of
contractile processes including smooth muscle contraction
(Sellers, 1991; Trybus, 1991), contraction of cultured cells
upon serum stimulation or treatment with certain drugs
(Giuliano et al., 1992; Kolodney and Elson, 1993; Goeck-
eler and Wysolmerski, 1995), stress fiber assembly upon
 
PP1c, catalytic subunit of type 1 protein phosphatase; RMLC, regulatory
myosin light chain. 
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serum stimulation of starved 3T3 cells (Chrzanowska-
Wodnicka and Burridge, 1996), and cytokinesis of higher
eukaryotic cells (Yamakita et al., 1994; Post et al., 1995;
DeBiasio et al., 1996; Jordan and Karess, 1997; Matsumura
et al., 1998).
Previously, it was demonstrated that during cell division
the sites of phosphorylation on RMLC changed (Satter-
white et al., 1992; Yamakita et al., 1994; Totsukawa et al.,
1996). The major phosphorylation site of interphase cells
is Ser 19. When cells enter mitosis, Ser 19 is no longer
phosphorylated, but Ser 1/2 become the major phosphory-
lation sites. During cytokinesis, Ser 1/2 phosphorylation is
switched back to Ser 19, and Ser 19 phosphorylation per-
sists during postmitotic cell spreading, suggesting that Ser
19 phosphorylation may activate contractile rings and is
required for stress fiber reassembly. These biochemical
studies are consistent with the observations that myosin II
phosphorylated on Ser 19 localized in cleavage furrows
(Post et al., 1995; DeBiasio et al., 1996; Matsumura et al.,
1998; Murata-Hori et al., 1998). Further, mutational analy-
sis of a 
 
Drosophila spaghetti squash
 
 gene encoding RMLC
revealed that phosphorylation of 
 
Drosophila
 
 RMLC on
Ser 21 (which corresponds to Ser 19 of vertebrate RMLC)
is essential for cell division (Jordan and Karess, 1997). A
notable exception is myosin II of 
 
Dictyostelium discoi-
deum
 
, where heavy chain phosphorylation, but not light
chain phosphorylation, is critical for the regulation of its
cell motility and cytokinesis (Uyeda and Spudich, 1993;
Hammer, 1994; Ostrow et al., 1994).
Phosphorylation of RMLC at Ser 19 is controlled by the
balance of two enzymatic activities, i.e., myosin light chain
kinase(s) and myosin phosphatase. While recent efforts
have focused on the functions of myosin phosphatase in
the regulation of smooth muscle contraction, the functions
of myosin phosphatase in nonmuscle cell motility are un-
clear. A trimeric myosin phosphatase is accepted as the
major protein phosphatase that is responsible for dephos-
phorylation of RMLC in smooth muscle and perhaps in
nonmuscle cells (see for review Hartshorne et al., 1998).
The holoenzyme consists of three subunits: a large subunit
of 
 
z
 
130 kD, a catalytic subunit of 38 kD, and a small sub-
unit of 20 kD (Alessi et al., 1992; Shimizu et al., 1994;
Shirazi et al., 1994). The catalytic subunit is the 
 
d
 
 isoform
of type 1 protein phosphatase (PP1c
 
d
 
). The small subunit
may be a regulatory subunit, but its function is unclear.
The large subunit is known as the myosin phosphatase tar-
geting subunit (MYPT) also referred to as M130/133
(Shimizu et al., 1994), M110 (Chen et al., 1994), or myosin
binding subunit (Okubo et al., 1994; Kimura et al., 1996).
MYPT can bind to both the catalytic subunit and myosin,
and thus will target the substrate, myosin, with the phos-
phatase. Without MYPT, PP1c showed low phosphatase
activity toward myosin, indicating a critical role of MYPT
in myosin dephosphorylation (Alessi et al., 1992; Hirano
et al., 1997; Johnson et al., 1997).
Recently there have been several reports that phosphor-
ylation of MYPT may modulate phosphatase activity. Ini-
tially, it was found that incubation of 
 
a
 
-toxin permeabi-
lized rabbit portal vein with ATP
 
g
 
S caused inhibition of
phosphatase activity and concomitant thiophosphoryla-
tion of MYPT (Trinkle-Mulcahy et al., 1995). Next it was
shown that MYPT was phosphorylated by an unknown ki-
 
nase copurified in the phosphatase holoenzyme prepara-
tions from smooth muscle and that this phosphorylation
inhibited phosphatase activity (Ichikawa et al., 1996). The
major site of phosphorylation of MYPT was T654 or T695
for the M130 and M133 MYPT isoforms, respectively.
Subsequently, Rho-kinase was shown to phosphorylate
MYPT in the COOH-terminal region and this phosphory-
lation inhibited phosphatase activity (Kimura et al., 1996).
It is known that Rho A is involved in the Ca
 
2
 
1
 
-sensitiza-
tion process in smooth muscle (see for review Somlyo and
Somlyo, 1994; Hartshorne et al., 1998) and the possibility
that this is due to inhibition of myosin phosphatase via
phosphorylation of MYPT by Rho-kinase is attractive
(Uehata et al., 1997). It has also been suggested that a sim-
ilar mechanism of phosphatase inhibition could initiate ac-
tivation of contractile rings during cytokinesis (Amano et
al., 1996). Finally, the in vitro phosphorylation of MYPT
in its COOH-terminal region by protein kinase A resulted
in a decreased binding to acidic phospholipids (Ito et al.,
1997). This observation led to the hypothesis that within
the cell, binding of MYPT to the cell membrane may be
regulated by cAMP.
The changes in the phosphorylation states of RMLC
during cell division (Satterwhite et al., 1992; Yamakita et
al., 1994; Totsukawa et al., 1996; Matsumura et al., 1998)
suggest the presence of regulatory mechanisms of RMLC
phosphorylation that involve kinases and/or phosphatases.
Based on the above discussion, it was thought that one
reasonable possibility was the phosphorylation of MYPT
and modification of myosin phosphatase activity. In this
paper, we demonstrate that MYPT is phosphorylated in a
mitosis-specific way. Unlike phosphorylation by other ki-
nases reported so far, the mitosis-specific phosphorylation
provides a positive regulatory effect on phosphatase activ-
ity. Phosphorylated MYPT shows an increased myosin
binding ability, resulting in the activation of phosphatase
during mitosis. Such activation would increase the dephos-
phorylation of RMLC and thus promote the disassembly
of stress fibers during prophase. The mitosis-specific mod-
ifications, i.e., phosphorylation of MYPT and activation of
phosphatase activity, are lost as the cell enters cytokinesis.
The reduced level of phosphatase activity may then lead to
increased myosin phosphorylation and activation of con-
tractile rings.
 
Materials and Methods
 
Cell Culture
 
SV-40 transformed rat embryo cells (REF-2A) were maintained in DME
containing 10% newborn calf serum in an atmosphere of 5% CO
 
2
 
 and
95% air at 37
 
8
 
C. CHO cells were maintained in F12 medium containing
10% fetal bovine serum. REF-2A cells at mitotic and later stages of cell
division were prepared as described previously (Yamashiro et al., 1990;
Hosoya et al., 1993; Yamakita et al., 1994). Briefly, cells were first treated
for 3 h with 0.25 
 
m
 
g/ml nocodazole, and mitotic cells (prometaphase) were
collected. After washing with ice-cold DME to remove nocodazole, cells
were plated in fresh culture dishes and incubated at 37
 
8
 
C in DME contain-
ing 10% newborn calf serum to allow cell cycle progression. Mitotic cells
recovered spindles at 10Ð20 min after release of nocodazole arrest, and
underwent cytokinesis at 40Ð60 min. In some experiments, REF-2A cells
at each mitotic stage were labeled with 
 
32
 
P-orthophosphoric acid as de-
scribed previously (Yamashiro et al., 1990; Hosoya et al., 1993; Yamakita
et al., 1994). 
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Antibodies
 
The following antibodies against MYPT were used: a polyclonal antibody
(pAb; rabbit) raised against the NH
 
2
 
-terminal 38 residues of chicken giz-
zard MYPT, termed Ab
 
1Ð38
 
 (Berkeley Antibody Co.; Muranyi et al., 1998);
pAb (rabbit) raised against residues 1Ð296 of gizzard MYPT, affinity puri-
fied using the MYPT fragment 1Ð296, termed Ab
 
1Ð296
 
; and mAb (IgG1)
raised against the gizzard phosphatase holoenzyme (Berkeley Antibody
Co.; Trinkle-Mulcahy et al., 1995). Other antibodies were mAb against
the type 1 phosphatase catalytic subunit, PP1c (Transduction Labs.), and
mAb against the polyhistidine tag (Sigma Chemical Co.).
 
Protein Preparations
 
Trimeric myosin phosphatase was purified from chicken gizzard according
to the method of Alessi et al. (1992). Nonmuscle myosin II was purified
from bovine lung as described (Sellers, 1991). For the preparation of Ser
19-phosphorylated myosin, purified myosin was incubated for 30 min at
25
 
8
 
C with 10 
 
m
 
g/ml myosin light chain kinase (MLCK) and 5 
 
m
 
g/ml cal-
modulin in 30 mM Tris-HCl (pH 7.5), 0.1 M KCl, 1 mM MgCl
 
2
 
, 0.1 mM
CaCl
 
2
 
, and 0.1 mM ATP (with or without 0.1 mCi/ml [
 
g
 
-
 
32
 
P]ATP). Phos-
phorylated myosin was dialyzed extensively against 20 mM Tris-HCl (pH
7.5), 1 M KCl, 1 mM MgCl
 
2
 
, and 0.1 mM DTT. Recombinant protein
phosphatase type 1 catalytic subunit, 
 
a
 
 isoform (PP1c
 
a
 
), was purchased
from Calbiochem-Novabiochem.
 
Immunoprecipitation and Immunoblotting
 
Immunoprecipitation of MYPT was performed using two different buffers
(buffer I and II). Buffer I contains 30 mM Tris-HCl (pH 7.5), 150 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.5% NP-40,
25 mM NaF, 100 mM sodium pyrophosphate, 50 mM 
 
b
 
-glycerophos-
phate, 1 mM sodium vanadate, 1 mM DTT, 1 mM benzamidine, 10 
 
m
 
g/ml
leupeptin, 10 
 
m
 
g/ml aprotinin, and 1 mM PMSF. Due to the high salt con-
centration of buffer I, MYPT was immunoprecipitated without the cata-
lytic subunit. Immunoprecipitation of MYPT with buffer I was used for the
myosin binding experiments. Buffer II was a lower ionic strength and was
the same as buffer I except for omission of NaF and sodium vanadate, and
reduction 25 mM sodium pyrophosphate and 20 mM 
 
b
 
-glycerophosphate.
Using buffer II, MYPT was immunoprecipitated in the myosin phos-
phatase complex and was used to determine myosin phosphatase activity.
Mitotic or interphase REF-2A cells were lysed in either immunoprecip-
itation buffer I or II. Cells were homogenized with a Dounce homogenizer
and clarified by centrifugation at 16,000 
 
g
 
 for 15 min. Cell lysates were
stored at 
 
2
 
80
 
8
 
C. After thawing quickly, the lysates were again centrifuged
at 16,000 
 
g
 
 for 15 min. Ab
 
1Ð296
 
 or Ab
 
1Ð38
 
 was added to the supernatants and
incubated for 2 h at 4
 
8
 
C. The immunocomplex was precipitated with pro-
tein AÐSepharose (Pharmacia Biotech, Inc.) during a 1-h incubation. The
immunocomplex was washed three times with each buffer, once with PBS,
and analyzed by SDS-PAGE followed by Western blotting. The immuno-
precipitated MYPT also was used for myosin binding or phosphatase as-
says.
Immunoblotting was performed as follows. Polyvinylidene difluoride
(PVDF) membranes were blocked with 5% nonfat dried milk in PBS, and
then incubated with the primary antibody (1:1,000 dilution) containing
0.3% BSA in PBS. Immunoreactive bands were detected with peroxidase-
conjugated secondary antibody (1:1,000 dilution) using a chemilumines-
cence method (New England Nuclear).
 
Protein Phosphatase Treatment of MYPT
 
Rat MYPT was prepared by immunoprecipitation using buffer I as de-
scribed above. Half of the immunoprecipitate was treated for 30 min at
30
 
8
 
C with one unit of recombinant serine/threonine phosphatase (PP1c
 
a
 
from rabbit skeletal muscle; Calbiochem-Novabiochem) in 20 mM Tris-
HCl (pH 7.5), 50 mM NaCl, 1 mM MnCl
 
2
 
, 2 mM MgCl
 
2
 
, 1 mM DTT, 0.1
mg/ml BSA, and 1 mM PMSF. Both treated and untreated samples were
analyzed by SDS-PAGE followed by Western blotting.
 
Phosphorylation of MYPT with Xenopus Egg Extracts
 
Mitotic or interphase extracts of 
 
Xenopus
 
 eggs were used to reconstitute
cell cycle-dependent phosphorylation of MYPT. Mitotic extracts were
prepared from 
 
Xenopus
 
 unfertilized eggs in an XB buffer containing 20 mM
Hepes (pH 7.7), 0.1 M KCl, 2 mM MgCl
 
2
 
, 0.1 mM CaCl
 
2
 
, 5 mM EGTA,
and 0.1 mg/ml cytochalasin D as described (Murray, 1991). Interphase ex-
 
tracts were prepared from mitotic extracts by the addition of 0.5 mM
CaCl
 
2
 
 followed by incubation at 20
 
8
 
C for 30 min to inactivate MPF.
Rat MYPT was prepared from interphase REF-2A cells by immuno-
precipitation with Ab
 
1Ð296
 
-conjugated Sepharose beads (cross-linked with
dimethylpimelimidate; Pierce Chemical Co.). Buffer I and II were used
for myosin binding studies and myosin phosphatase assays, respectively.
Purified chick gizzard myosin phosphatase was also bound to the same an-
tibody-conjugated beads. MYPT-bound beads were washed once with XB
buffer (without cytochalasin), mixed with an equal volume of mitotic or
interphase extracts, and incubated at 25
 
8
 
C for 30 min in the presence of
1 mM ATP (with or without 1 mCi/ml [
 
g
 
-
 
32
 
P]ATP). The beads were
washed extensively with buffer I or II, and then subjected to SDS-PAGE,
immunoblotting, two-dimensional tryptic phosphopeptide mapping, myo-
sin binding, or phosphatase assays.
A peptide (NH
 
2
 
-ISPKEEERKDESPASWRLGLRKC-COOH) corre-
sponding to residues 421Ð442 of rat MYPT (which corresponds to Val 416-
Lys 437 of chicken MYPT) was commercially synthesized (Bio-Synthesis
Inc.). The peptide (20 
 
m
 
g) was phosphorylated with 
 
Xenopus
 
 mitotic ex-
tracts in the presence of 1 mCi/ml [
 
g
 
-
 
32
 
P]ATP as described above. Trichlo-
roacetic acid was added to 10% to precipitate proteins and the phosphory-
lated peptide was recovered by centrifugation in the supernatant. The
peptide was then separated by Tricine-SDS-PAGE (Schagger and von
Jagow, 1987). The phosphorylated peptide was detected by autoradiogra-
phy, excised from Tricine-SDS gels, and digested with TPCK-treated
trypsin followed by two-dimensional phosphopeptide mapping.
 
Construction of Mutants of MYPT
 
cDNA encoding chicken MYPT304Ð511 was subcloned into a pQE32 vec-
tor (QIAGEN, Inc.) with a hexahistidine tag at the NH
 
2
 
 terminus as de-
scribed (Hirano et al., 1997). NH
 
2
 
- and COOH-terminal truncations were
made by PCR amplification with pQE32-MYPT304Ð511 as a template.
The sense and antisense primers were designed to contain BamHI and
SalI sites at 5
 
9
 
 and 3
 
9
 
 ends, respectively, to ligate the PCR products unidi-
rectionally into the pQE32 vector. After digestion of the PCR prod-
ucts with BamHI and SalI, they were inserted into the BamHI- and
SalI-digested pQE32 vector. The truncation mutants obtained were
MYPT304Ð410, MYPT304Ð444, MYPT421Ð511, and MYPT432Ð511.
These proteins were expressed in 
 
Escherichia coli
 
 and purified by a metal
affinity column (Sigma Chemical Co.) as described (Hirano et al., 1997).
Site-directed mutagenesis was performed using a QuickChange site-
directed mutagenesis kit (Stratagene). For the mutation of Ser 427 to Asp,
a forward primer, 5
 
9
 
-GAAGAGAGGAAAGATGAAGATCCTGCT-
TCGTGGAGGTTAG-3
 
9
 
, and a reverse primer, 5
 
9
 
-CTAACCTCCAC-
GAAGCAGGATCTTCATCTTTCCTCTCTTC-3
 
9
 
, were used. For the
mutation of Ser 430 to Glu, a forward primer, 5
 
9
 
-GAAAGATGAATC-
TCCTGCTGAGTGGAGGTTAGGTCTTCG-3
 
9
 
, and a reverse primer,
5
 
9
 
-CGAAGACCTAACCTCCACTCAGCAGGAGATTCATCTTTC-3
 
9
 
,
were used. PCR was performed with pQE32-MYPT304Ð511 as a template
with Pfu polymerase, according to the manufacturerÕs instructions (Strat-
agene).
 
Myosin Binding Assay
 
This assay was performed as follows. Rat MYPT was immunoprecipitated
from mitotic or interphase cells using Ab
 
1Ð296
 
 with buffer I, and eluted
from the Sepharose beads by incubating for 2 min with 0.1 M glycine, pH
2.3, containing 0.1 mg/ml BSA, followed by immediate neutralization with
2 M Tris base. The eluted MYPT was mixed with phosphorylated myosin
(0.1 
 
m
 
M) in 30 mM Tris-HCl (pH 7.5), 50 mM KCl, 1 mM MgCl
 
2
 
, 0.1 mg/ml
BSA, and 0.5 mM ATP. Samples were incubated at 4
 
8
 
C for 10 min, and
myosin was precipitated by centrifugation at 16,000 
 
g
 
 for 10 min. Both pel-
let and supernatant were added to an equivalent volume of SDS sample
buffer and subjected to SDS-PAGE followed by immunoblotting analysis.
The amount of MYPT was estimated densitometrically by scanning immu-
noreactive bands using purified chicken MYPT as a standard.
Myosin binding was also examined with in vitro phosphorylated
MYPT. Rat MYPT was immunoprecipitated from interphase cells using
buffer I and phosphorylated in vitro with 
 
Xenopus
 
 mitotic or interphase
extracts as described above. Phosphorylated MYPT was eluted from the
immunocomplex and used for myosin binding, as described above.
 
Myosin Phosphatase Assay
 
Rat MYPT was immunoprecipitated from interphase cells using Ab
 
1Ð38
 
with buffer II and phosphorylated (without radioactive ATP) in vitro us- 
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ing 
 
Xenopus
 
 mitotic or interphase extracts as described above. After ex-
tensive washing, immobilized myosin phosphatase was incubated at 30
 
8
 
C
with 
 
32
 
P-labeled myosin (0.5 
 
m
 
M) in 30 mM Tris-HCl (pH 7.5), 0.1 M KCl,
2 mM MgCl
 
2
 
, and 0.1 mg/ml BSA. The reaction was terminated by the ad-
dition of trichloroacetic acid and BSA to final concentrations of 10% and
3 mg/ml, respectively. After centrifugation, the radioactivities of the su-
pernatants were determined by Cerenkov counting. The reaction time was
adjusted so that 
 
z
 
10Ð20% of the substrate was dephosphorylated. In
some experiments, the gizzard myosin phosphatase was used to examine
effects of phosphorylation on myosin phosphatase activity.
 
Other Procedures
 
Two-dimensional tryptic phosphopeptide mapping was performed using
cellulose thin layer plates as described in Boyle et al. (1991). Phosphopep-
tides were detected by autoradiography. SDS-PAGE was performed as
described by Blatter et al. (1972) using 12.5% polyacrylamide gel and the
Laemmli buffer system (Laemmli, 1970). Protein concentrations were de-
termined by the method of Bradford (1976) using BSA as standard.
 
Results
 
Mitosis-specific Phosphorylation of MYPT
 
Initially a mitosis-specific modification of MYPT was ob-
served by immunoblotting the mitotic cell lysates with the
mAb specific for MYPT. As Fig. 1 a shows, the mAb did
not detect a band in the total cell lysates of mitotic cells
(lane 4) but the same mAb reacted strongly with MYPT
from interphase cells (lane 3). The lack of reactivity in mi-
totic cell lysates was not due to degradation of MYPT dur-
ing mitosis because the pAb, Ab
 
1
 
Ð
 
38
 
, reacted equally well
with MYPT from either interphase (lane 1) or mitotic
(lane 2) cells. In addition, in cells rounded by trypsin treat-
ment the reactivity of MYPT with the mAb was retained
(data not shown). Thus it is suggested that the loss of rec-
ognition of the mAb for MYPT was due to a modification
of MYPT incurred during mitosis.
One possibility was that the lack of reactivity to the
mAb was due to mitosis-specific phosphorylation. To test
this idea, mitotic and interphase MYPT were immunopre-
cipitated, and divided into two aliquots. One aliquot was
used as a control and the other was incubated with PP1c
 
a
 
.
The phosphatase treatment completely restored the reac-
tivity of mitotic MYPT with the mAb (Fig. 1 b; compare
lanes 2 and 4 of the upper panel), indicating that the lack
of reactivity to the mAb is due to mitosis-specific phos-
phorylation. It should also be noted that MYPT from mi-
totic cells showed a subtle but significant upward shift of
mobility on SDS-PAGE (compare lanes 1 and 2 of the
lower panel), and that the same phosphatase treatment
eliminated this shift (see lanes 2 and 4 of the lower panel).
In contrast, incubation with phosphatase of MYPT from
interphase cells did not affect its reactivity with the mAb
(Fig. 1 b; compare lanes 1 and 3). These results indicate
that serine/threonine phosphorylation is responsible for
the mitosis-specific modification of MYPT.
Next, a time course of the mitosis-specific phosphoryla-
tion during cell division was examined. Total cell lysates
were prepared from interphase cells, mitotic cells, and
cells at different stages of cell division (see Materials and
Methods). MYPT was analyzed in each preparation by im-
munoblotting using the same mAb and pAb. Immunoblots
with the mAb clearly demonstrated that a mitosis-specific
phosphorylation of MYPT occurred and was dependent
on the cell cycle stage. As Fig. 1 c (upper panel) shows, mi-
totic MYPT (lane M) exhibited complete loss of reactivity
against the mAb, whereas interphase MYPT (lane I)
showed a strong reaction to the same antibody. The lack of
reactivity continued until 40 min after release of mitotic
arrest and then was recovered at 60 min, at which point cy-
tokinesis occurred. At later phases when the cell was in-
volved in postmitotic spreading (80Ð180 min), the reactiv-
ity of MYPT to the mAb was similar to that of interphase
cells.
The lack of reactivity to the mAb parallels the mobility
shift observed with the pAb. An immunoblot with the
pAb (Fig. 1 c, lower panel) reveals that MYPT showed a
slight upward shift in mobility during mitosis (compare
lanes I and M). The upward shift was apparent until 40
min and then was reversed at 60 min. These results again
indicate that MYPT was dephosphorylated during cytoki-
Figure 1. Mitosis-specific phosphorylation of MYPT. (a) Mitotic
MYPT loses a reactivity to the mAb specific to MYPT. Total cell
lysates of interphase (lanes 1 and 3) or mitotic cells (lanes 2 and
4) were immunoblotted with rabbit pAb (lanes 1 and 2) or mouse
mAb (lanes 3 and 4). The arrow indicates the position of MYPT
(130 kD). Molecular mass markers are indicated in kD at the left
of the figure. (b) Treatment with PP1c restores the reactivity of
mitotic MYPT to the mAb. MYPT was immunoprecipitated from
interphase (lanes 1 and 3) or mitotic cells (lanes 2 and 4). Half of
the immunoprecipitate was treated with PP1c (lanes 3 and 4).
Both treated or untreated samples were immunoblotted with the
mAb or pAb. (c) Time course of mitosis-specific modification of
MYPT during cell division. Total cell lysates were prepared from
interphase cells (lane I), mitotic cells (lane M), and cells at differ-
ent stages of cell division (time in minutes after the release of mi-
totic arrest), and blotted with either the mAb or the pAb. Cyto-
kinesis occurred 40Ð60 min after release of mitotic arrest. 
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nesis. We have also observed similar modifications of
MYPT during mitosis of other cells including CHO cells
(data not shown).
 
The Sites of Mitosis-specific Phosphorylation Differ 
from Those Observed during Interphase
 
To examine whether net phosphate incorporation into
MYPT was increased during mitosis, MYPT was immuno-
precipitated from interphase and mitotic cells after in vivo
labeling with 
 
32
 
P-orthophosphate. As Fig. 2 a shows, the
level of phosphorylation of mitotic MYPT (lane 2) is simi-
lar to that of interphase MYPT (lane 1). One explanation
for the lack of reactivity to the mAb could be that differ-
ent sites were phosphorylated in the two stages, rather
than a net increase in phosphorylation during mitosis.
To examine this possibility, two-dimensional phospho-
peptide mapping was performed. MYPT was again immu-
noprecipitated from mitotic and interphase cells labeled in
vivo with 
 
32
 
P-orthophosphate, digested with trypsin, and
analyzed by peptide mapping. Fig. 2 b shows the phospho-
peptide maps generated with interphase (I) and mitotic
(M) MYPT. To identify which spots are mitosis-specific, a
mixture of mitotic and interphase MYPT samples was sub-
jected to peptide mapping (Mix). The map of mitotic
MYPT (M) revealed four mitosis-specific phosphopeptide
spots (indicated by M1Ð4). In addition, one spot (M5)
showed a considerably higher intensity in mitotic MYPT.
On the other hand, the interphase map (I) gives two inter-
phase-specific spots (indicated by I). There are four spots
(indicated by C) which were observed commonly in both
mitotic and interphase MYPT maps. These results demon-
strate that the sites of phosphorylation were different be-
tween mitotic and interphase MYPT. We also examined
the phosphopeptide pattern of MYPT prepared from cells
at 120 min after the release of mitotic arrest. This pattern
was identical to that shown with interphase cells (data not
shown). This is consistent with the result that the reactivity
of MYPT to the mAb at 120 min was similar to that of
MYPT from interphase cells.
 
In Vitro Reconstitution of Mitosis-specific 
Phosphorylation MYPT
 
To further characterize mitosis-specific phosphorylation,
 
Figure 2.
 
Phosphopeptide analysis of mitotic and interphase
MYPT and in vitro reconstitution of mitosis-specific phosphory-
lation of MYPT. (a) In vivo phosphorylation of MYPT from in-
terphase or mitotic cells. MYPT was isolated by immunoprecipi-
tation from interphase (lane 1) or mitotic cells (lane 2) that had
been labeled with 
 
32
 
P-orthophosphate. 
 
32
 
P-labeled MYPT was
separated by SDS-PAGE followed by autoradiography. (b) Two-
dimensional tryptic phosphopeptide mapping analysis of in vivo
phosphorylated MYPT. I, MYPT isolated from interphase; M,
MYPT from mitotic cells; Mix, a mixture of mitotic and inter-
phase MYPT; M1Ð4, phosphopeptide spots specifically observed
in mitotic map; M5, a spot whose intensity is increased in mitotic
map. Phosphopeptide spots specifically observed in interphase
map and spots commonly observed in both interphase and mi-
totic MYPT are labeled with I and C, respectively. Arrow with e,
electrophoretic dimension; arrow with c, chromatographic di-
mension; ori, the origin. (c) In vitro reconstitution of mitotic
phosphorylation. Interphase MYPT was prepared by immuno-
precipitation and phosphorylated with 
 
Xenopus
 
 mitotic or inter-
phase extracts. Both samples were separated by SDS-PAGE fol-
lowed by immunoblotting using the mAb or pAb. Lane 1, a
control without addition of 
 
Xenopus
 
 extracts; lane 2, MYPT
treated with mitotic extracts; lane 3, MYPT treated with inter-
phase extracts. (d) Phosphopeptide mapping analysis of in vitro
phosphorylated MYPT. MYPT was phosphorylated in vitro using
 
Xenopus
 
 mitotic extracts and analyzed by phosphopeptide map-
ping (X). For comparison, a mixture of in vivo and in vitro phos-
phorylated MYPT (Mix) is shown. The mitosis-specific spots are
indicated by M. 
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an attempt was made to reconstitute the mitosis-specific
phosphorylation in vitro. Mitotic 
 
Xenopus
 
 egg extracts
were used as a kinase fraction. MYPT was immunoprecip-
itated from interphase cultured rat cells using buffer I, and
aliquoted into two. One-half was incubated with mitotic
 
Xenopus
 
 extracts in the presence of Mg-ATP. As a con-
trol, the other half was incubated with interphase 
 
Xenopus
 
extracts that had been prepared from mitotic extracts fol-
lowing the addition of Ca
 
2
 
1
 
 (which converted mitotic
extracts into interphase extracts; see Murray, 1991 and
Materials and Methods). The incubation with the mitotic
extracts eliminated the reactivity of MYPT against the
mAb (Fig. 2 c, upper panel, lane 2). At the same time, the
mobility of MYPT showed an upward shift (Fig. 2 c, lower
panel, lane 2) when compared with the mobility of un-
treated MYPT (lane 1). In contrast, incubation with the in-
terphase extracts did not alter the reactivity to the mAb
nor did it induce the mobility shift (lane 3). These results
suggest that 
 
Xenopus
 
 mitotic extracts are able to reconsti-
tute the mitosis-specific phosphorylation.
To confirm the reconstitution of MYPT, the phosphory-
lation sites of MYPT were analyzed by two-dimensional
phosphopeptide mapping. As indicated in Fig. 2 d, the
phosphopeptide map of MYPT phosphorylated in vitro by
mitotic 
 
Xenopus
 
 extracts (X) was similar to that phos-
phorylated in vivo in mitotic cells (compare M, Fig. 2 b).
For comparison, a mixture of in vivo and in vitro phosphor-
ylated MYPT was subjected to phosphopeptide mapping
(Mix, Fig. 2 d). The map of MYPT phosphorylated by 
 
Xe-
nopus
 
 mitotic extracts showed four (M1Ð3, M5) out of the
five mitotic-specific spots, although two interphase specific
spots (I) appeared simultaneously. The spot M4 could be
seen only after prolonged exposure of the autoradiograph
(data not shown). On the other hand, MYPT phosphory-
lated by interphase extracts yielded a map similar to that
of interphase MYPT (data not shown).
 
Identification of a Mitosis-specific Phosphorylation Site
 
The loss of reactivity to the mAb indicated that the
epitope of the mAb may contain a site of mitosis-specific
phosphorylation. It was known that the epitope to the
mAb was between residues 371 and 511 (Hartshorne, D.J.,
unpublished results) and to define more precisely the
epitope a series of truncation mutants was analyzed. In
Fig. 3 a it is shown that fragment 421Ð511 has a positive re-
action with the mAb while 432Ð511 was negative, indicat-
ing that the epitope is localized between residues 421 and
432. There are two serines (no threonine) in this sequence,
Ser 427 and Ser 430 (Fig. 3 b), and these two residues were
mutated to Asp and Glu, respectively. The resultant point
mutants were expressed in bacteria, and the reactivities of
these two mutants to the mAb were examined by immuno-
 
Figure 3.
 
Identification of one of the mitosis-specific phosphory-
lation sites of MYPT. (a) Schematic presentation of the truncated
mutants of chick MYPT. The reactivities to the mAb of truncated
mutants are shown. MYPT truncated mutants were immunoblot-
ted with the mAb against MYPT. The protein expression in bac-
teria was confirmed with an antipolyhistidine antibody. The
epitope of the mAb should be located between 421 and 432. (b)
 
The epitope region of MYPT to the mAb. The sequence shown is
Glu 421 to Arg 432 of chick MYPT (which corresponds to Glu
426 to Arg 437 of rat MYPT), and contains two serine residues of
Ser 427 and Ser 430. To mimic phosphorylation, Ser 427 and Ser
430 were mutated to Asp (S427D) and Glu (S430E), respectively,
and the mutants were expressed in bacteria. (c) Immunoblot
analysis of the phosphorylation-mimicking mutants of MYPT.
The S427D and S430E mutants were separated by SDS-PAGE
followed by immunoblotting analysis using the antipolyhistidine
antibody or the mAb against MYPT. Lane 1, wild-type
MYPT304-511; lane 2, S427D mutant; lane 3, S430E mutant. (d)
Phosphopeptide mapping analysis of a synthetic peptide (NH
 
2
 
-
ISPKEEERKDESPASWRLGLRKC-COOH) containing Ser
430. P, peptide map of the synthetic peptide phosphorylated by
 
Xenopus
 
 mitotic extracts; X, map of rat MYPT phosphorylated
by 
 
Xenopus
 
 mitotic extracts; Mix, a map of a mixture of the syn-
thetic peptide and MYPT. The two spots in P (indicated by ar-
rows) match M2 and M3 of mitotic spots.Totsukawa et al. Mitosis-specific Phosphorylation of Myosin Phosphatase 741
blotting. It was found that mutation of Ser 430 to Glu
(S430E) resulted in complete loss of reactivity (lane 3 of
Fig. 3 c). In contrast, the mutant replacing Ser 427 with
Asp (S427D) still showed a strong reactivity to the mAb,
though the reactivity was weaker than the control (lane 2
of Fig. 3 c). A reasonable conclusion from these results is
that Ser 430 of MYPT is a site phosphorylated during mi-
tosis, although it is possible that simultaneous phosphory-
lation at Ser 427 may also occur.
To further test whether Ser 430 is one of the mitosis-spe-
cific phosphorylation sites, a peptide containing Ser 430
(from residues 421Ð442 of rat MYPT) was synthesized and
phosphorylated in vitro using Xenopus mitotic extracts.
The peptide was digested with trypsin and subjected to
two-dimensional phosphopeptide mapping. A map from
the phosphorylated synthetic peptide (P, Fig. 3 d) yielded
several spots, apparently due to incomplete trypsin diges-
tion (the peptide has multiple lysine and arginine resi-
dues). To examine whether any of these spots matched the
mitotic spots, the map generated from the phosphorylated
synthetic peptide was compared with a map from MYPT
phosphorylated with Xenopus extracts (X), and with a
map of a mixture from the peptide and MYPT samples
(Mix). It was found that two major spots (indicated by ar-
rows) of the map generated from the synthetic peptide
correspond to two mitotic spots, M2 and M3. These re-
sults, together with the mutational analyses, indicate that
the spots, M2 and M3, are derived from mitosis-specific
phosphorylation at Ser 430. Again, there is the possibility
that Ser 427 may also be phosphorylated. It should be
noted that there are other mitosis-specific phosphoryla-
tion sites corresponding to the mitotic spots of M1, M4,
and M5.
Increased Myosin Binding Ability of Mitotic
MYPT and Higher Phosphatase Activity Shown by 
Mitotic Myosin Phosphatase
To explore the functional significance of mitosis-specific
phosphorylation of MYPT, the myosin binding activities
of MYPT from mitotic or interphase cells were compared.
Mitotic and interphase MYPT were immuno-affinity puri-
fied, and their myosin binding abilities were examined us-
ing phosphorylated myosin in the presence of Mg-ATP, as
described in Materials and Methods. As Fig. 4 a shows, the
amount of mitotic MYPT bound to phosphorylated myo-
sin was about threefold higher than MYPT from inter-
phase cells.
Because the quantity of MYPT isolated from mitotic
cells was limited, the in vitro reconstitution system was
used to prepare mitotic and interphase MYPT, allowing a
more extensive evaluation of the myosin-binding proper-
ties of MYPT, i.e., to use a wider range of MYPT concen-
trations. Rat MYPT immunoprecipitates (using buffer I)
were phosphorylated by either mitotic or interphase ex-
tracts, as described above, and then MYPT was eluted
from the immunocomplexes. Varying concentrations of
eluted MYPT (2Ð25 nM) were mixed with phosphorylated
myosin in the presence of Mg-ATP and their binding was
examined. As Fig. 4 b shows, the amount of MYPT bound
to phosphorylated myosin was two to three times higher
using MYPT phosphorylated with mitotic extracts com-
pared to the MYPT phosphorylated by interphase ex-
tracts. At 25 nM MYPT, it was found that z68% of MYPT
phosphorylated by mitotic extracts bound to myosin while
only 31% of MYPT phosphorylated by interphase extracts
bound to myosin. These results support the data obtained
for in vivo phosphorylation of MYPT (compare with
Fig. 4 a).
The enhanced myosin binding activity of mitotic MYPT
suggested that myosin phosphatase activity may be in-
creased during mitosis. To test this possibility, MYPT was
immunoprecipitated using buffer II (to retain the catalytic
subunit in complex with MYPT), phosphorylated with ei-
ther Xenopus mitotic or interphase extracts, and used to
assay phosphatase activities. Again, the MYPT phosphor-
ylated with Xenopus mitotic extracts showed loss of reac-
tivity to the mAb (lane 2 of the upper panel of Fig. 5 a), in-
dicating that mitosis-specific phosphorylation of MYPT
occurred. It was also confirmed, by immunoblotting with
the pAb against MYPT and with the mAb to PP1c (middle
and lower panel of Fig. 5 a), that essentially identical
amounts of MYPT and the catalytic subunit were present
in the immunoprecipitates treated with mitotic or inter-
phase Xenopus extracts. As Fig. 5 b shows, the myosin
phosphatase treated with mitotic extracts had approxi-
mately twice the activity than that treated with interphase
extracts. Similar results were obtained with chick gizzard
myosin phosphatase (data not shown). These results indi-
cate that the enhanced myosin binding ability was accom-
panied by a higher phosphatase activity.
Discussion
In this paper we have demonstrated that MYPT is phos-
Figure 4. Increased myosin
binding ability of mitotic
MYPT. (a) Mitotic or inter-
phase MYPT was prepared
by immunoaffinity purifica-
tion and myosin binding ac-
tivity was determined by
cosedimentation assay with
phosphorylated myosin as
described in Materials and
Methods. The figure shows
myosin binding of MYPT
prepared from interphase
cells (I) or mitotic cells (M).
The values shown are the
means  6 SEM from three in-
dependent experiments. (b)
Myosin binding activity of in
vitro phosphorylated MYPT.
MYPT was phosphorylated
in vitro with Xenopus mitotic
or interphase extracts and
myosin binding ability was
examined as described in
Materials and Methods.
MYPT phosphorylated with
mitotic extracts (j); MYPT
phosphorylated with inter-
phase extracts (s).The Journal of Cell Biology, Volume 144, 1999 742
phorylated in a mitosis-specific way, and that phosphoryla-
tion increases its myosin binding ability, as well as myosin
phosphatase activity. The activation of myosin phospha-
tase by mitosis-specific phosphorylation is unique as
it provides a positive regulatory mechanism for myosin
phosphatase distinct from previous reports on phosphory-
lation of MYPT. For example, phosphorylation by Rho-
kinase (Kimura et al., 1996) or by endogenous kinase
(Ichikawa et al., 1996) was reported to inhibit the activity
of myosin phosphatase. Phosphorylation by protein kinase
A was found to decrease the association of MYPT with
lipids (Ito et al., 1997), which was suggested as a mecha-
nism to regulate association of MYPT with membranes.
Activation of myosin phosphatase via the cGMP-depen-
dent protein kinase has been proposed (Wu et al., 1996;
Lee et al., 1997) but the mechanism of activation has not
been established.
Mechanism of Activation of Myosin Phosphatase by 
Mitosis-specific Phosphorylation
Ser 430 (which corresponds to Ser 435 in rat MYPT) was
identified as one of the mitosis-specific phosphorylation
sites. It should be noted that the sequence surrounding Ser
430 is well conserved among different species including
human, rat, and chicken, although Ser 430 is changed to
Thr 435 in humans (see for review Hartshorne et al., 1998).
In fact, chicken and rat MYPT have an identical sequence
of 42 amino acids around this phosphorylation site. There
are two genes that express MYPT, denoted MYPT1 and
MYPT2 (Takahashi et al., 1997; Fujioka et al., 1998). The
isoform examined in this article is MYPT1, and MYPT2 is
found in heart and brain. The putative mitosis-specific
phosphorylation site also is found in MYPT2 at Ser 437.
The sequence around this site, 428Ð447 of MYPT2 is 90%
identical to 421Ð440 of MYPT1. Thus, it is possible that
phosphorylation of this site on MYPT is a general mecha-
nism for activation of myosin phosphatase activity. It is in-
teresting that Ser 430 does not have a consensus sequence
for cdc2 kinase. Although cdc2 kinase can phosphorylate
MYPT in vitro, a phosphopeptide pattern generated by
cdc2 is different from the peptide map of MYPT phos-
phorylated in vivo during mitosis (data not shown). Like-
wise, NIM A kinase (Pu et al., 1995) does not seem to be
responsible because a phosphopeptide map generated by
NIM A kinase is quite different from the mitotic pattern
(data not shown). Clearly, identification of the kinase re-
sponsible for the mitosis-dependent phosphorylation is a
priority for future studies.
It is not clear at present how mitotic phosphorylation in-
fluences the binding of MYPT to myosin. One of the mito-
sis-specific phosphorylation sites, Ser 430 (Ser 427 may
be phosphorylated simultaneously) is located toward the
middle of the MYPT molecule. There is controversy re-
garding the location of the myosin-binding sites on MYPT.
It has been reported that the ankyrin repeats at the NH2-
terminal portion of MYPT are involved (Hirano et al.,
1997) and also that a COOH-terminal sequence is impli-
cated (Johnson et al., 1997). Neither part of the molecule
is close (in terms of linear sequence) to Ser 430. Therefore,
a direct influence of Ser 430 on either of the putative myo-
sin-binding sequences is not possible unless the MYPT
molecule bends, or folds, to accommodate such an interac-
tion. It is possible that other mitosis-specific phosphoryla-
tion sites on MYPT may be close to one of the myosin
binding sites and contribute to the myosin-binding effect.
Alternatively, phosphorylation of Ser 430 may induce a
longer-range conformational change at the myosin-bind-
ing site. Clearly, the solution to this problem requires the
identification of all of the mitosis-specific phosphorylation
sites as well as the region(s) of MYPT involved in interac-
tion with myosin.
It has been reported that cdc2 kinase phosphorylates
PP1c, and that phosphorylation inhibits its activity toward
phosphorylase a (Dohadwala et al., 1994). This seems to
be contradictory to the results presented here. However,
PP1c is involved in the dephosphorylation of several pro-
teins, and the activity toward each protein is dependent on
various targeting molecules. For example, the activity of
PP1c toward phosphorylase a is considerably decreased in
the presence of MYPT (Alessi et al., 1992; Johnson et al.,
1996; Hirano et al., 1997). The presence of target mole-
cules may also affect the accessibility of PP1c for phosphor-
ylation by cdc2 kinase. It is thus possible that phosphor-
ylation of PP1c by cdc2 kinase may not inhibit myosin
phosphatase activity during mitosis. This is based on the
following two reasons. First, an activation of myosin phos-
phatase, rather than inhibition, was found following phos-
phorylation with the Xenopus mitotic extracts (Fig. 5 b). If
phosphorylation of PP1c by cdc2 kinase and resultant inhi-
bition was a dominant mechanism it should have been de-
tected in these experiments. Second, the phosphorylation
of PP1c of chick myosin phosphatase by Xenopus mitotic
extracts was not observed (data not shown).
Figure 5. Myosin phos-
phatase activity of in vitro
phosphorylated myosin phos-
phatase. (a) Immunoblotting
analysis of in vitro phosphor-
ylated myosin phosphatase.
Interphase myosin phos-
phatase was prepared by im-
munoprecipitation and phos-
phorylated in vitro with
Xenopus interphase (lane 1)
or mitotic extracts (lane 2).
After extensive washing,
phosphorylated samples were
analyzed by immunoblotting
with the mAb, pAb against
MYPT, or anti-PP1c anti-
body. (b) Myosin phos-
phatase activity of the in
vitro phosphorylated myosin
phosphatase. Left column,
myosin phosphatase phos-
phorylated with interphase
extracts; right column, myo-
sin phosphatase phosphory-
lated with mitotic extracts.
The values shown are
means  6 SEM from three in-
dependent experiments.Totsukawa et al. Mitosis-specific Phosphorylation of Myosin Phosphatase 743
Physiological Significance
Mitosis-specific phosphorylation of MYPT may play a sig-
nificant role in the regulation of microfilament reorganiza-
tion during cell division of cultured cells. The enhanced
myosin phosphatase activity would increase the probabil-
ity for dephosphorylation of RMLC during prophase,
leading to the disassembly of stress fibers and cell round-
ing. This notion is consistent with our previous results
showing that Ser 19 phosphorylation is decreased when
cells enter mitosis (Yamakita et al., 1994). The increased
activity of myosin phosphatase and resultant disassembly
of stress fibers also are compatible with the localization of
MYPT during mitosis. MYPT was reported to show a dif-
fuse localization during mitosis (Ito et al., 1997) while it is
associated with microfilament structures such as stress fi-
bers and adhesion belts during interphase (Inagaki et al.,
1997; Murata et al., 1997).
In addition, the reversal of mitosis-specific phosphoryla-
tion, i.e., dephosphorylation, during cytokinesis negates
the activation of myosin phosphatase and thus would favor
a higher level of Ser 19 phosphorylation for the activation
of contractile rings. This idea again is consistent with pre-
vious results in that the phosphorylation sites on RMLC
change from S1/2 to Ser 19 during cytokinesis (Satterwhite
et al., 1992; Yamakita et al., 1994). This is supported by
our recent immunolocalization data using a Ser 19 phos-
phorylation specific antibody, in which prometaphase cells
showed a lower level of Ser 19 phosphorylation than cells
at telophase (Matsumura et al., 1998). These changes in
phosphatase activity would explain a previous observation
by Fishkind et al. (1991) that microinjection of a catalytic
fragment of MLCK (constitutively active MLCK) delayed
the onset of anaphase but did not alter the rate of progres-
sion of cytokinesis. Perhaps, the increased activity of myo-
sin phosphatase during prometaphase could counteract
phosphorylation of Ser 19 by the catalytic fragment of
MLCK before cytokinesis. The decrease in myosin phos-
phatase activity during cytokinesis would then be able to
regulate cleavage furrow contraction. If these speculations
are correct, then the mitosis-specific phosphorylation of
MYPT may play a pivotal role in the control of cell divi-
sion.
The positive regulatory mechanism of myosin phos-
phatase described above contrasts the negative regulation
by phosphorylation of MYPT with Rho-kinase. It is possi-
ble that both mechanisms collaborate to regulate the mas-
sive reorganization of microfilaments during cell division.
Our current model for regulation of myosin phosphatase
during cell division is shown in Fig. 6. This incorporates
two phosphorylation steps: an activation via the mitosis-
specific kinase(s), and an inhibition via Rho-kinase (Amano
et al., 1996; Kimura et al., 1996). It is therefore reasonable
to suggest that there are at least two functional phosphor-
ylation sites to reflect the positive and negative regulatory
effects. When cells enter prophase it is proposed that the
mitosis-specific phosphorylation occurs (via unknown ki-
nase) and this causes activation of myosin phosphatase
and a decrease in the level of myosin phosphorylation (at
Ser 19). The result is disassembly of stress fibers and cell
rounding. On exit from mitosis and before, or during cy-
tokinesis, the activating site(s) on MYPT are dephosphor-
ylated. At the same phase of the cell cycle it is suggested
that inhibition of myosin phosphatase occurs via phosphor-
ylation of MYPT by Rho-kinase. Here the next result
would be an increase in the level of myosin phosphoryla-
tion (at Ser 19) and activation of myosin for cell division.
There are important components of this scheme that must
be identified before a plausible mechanism can be estab-
lished, these include the kinase(s) and phosphatase(s) in-
volved at the mitosis-specific stage.
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